This report should be completed when a suspected adverse event or lack of efficacy is suspected in animals or humans during, or after the use of one of Norbrookâs Veterinary Medicines.
Upon receipt of this report, a member of the Pharmacovigilance department will contact with the reporter to investigate the event. The contact details of the reporter will be treated as confidential and will not be passed to anyone outside of Norbrook without permission.